TABLE 2. Summary of demographic data*.
Cyclosporine Groups | |||||
---|---|---|---|---|---|
Variable | I | II | III | IV | Placebo Group |
no. of patients | 8 | 8 | 8 | 8 | 8 |
M | 7 | 7 | 7 | 3 | 8 |
F | 1 | 1 | 1 | 5 | 0 |
GCS score (± SD) | 6.5 ± 0.93 | 5.5 ± 1.5 | 5.9 ± 0.99 | 6.3 ± 1.4 | 6.0 ± 0.76 |
4 | 1 | 1 | 1 | 1 | 1 |
5–7 | 7 | 6 | 7 | 4 | 7 |
8 | 0 | 1 | 0 | 3 | 0 |
age (± SD) | 29 ± 6.0 | 32 ± 14.6 | 23 ± 8.2 | 34 ± 14.8 | 6 ± 6.6 |
Marshall CT classification† | |||||
I | 0 | 0 | 0 | 0 | 0 |
II | 1 | 2 | 1 | 0 | 1 |
II + SAH | 1 | 3 | 3 | 4 | 2 |
III | 0 | 0 | 0 | 1 | 0 |
III + SAH | 2 | 0 | 1 | 0 | 0 |
V | 2 | 2 | 0 | 1 | 4 |
IV + SAH | 1 | 0 | 0 | 1 | 0 |
SAH only | 0 | 1 | 1 | 0 | 0 |
evacuated mass lesion | 1 | 0 | 1 | 0 | 0 |
nonevcuated mass lesion + SAH | 0 | 0 | 1 | 1 | 1 |
Values represent numbers of patients unless otherwise indicated. Abbreviations: SAH = subarachnoid hemorrhage; SD = standard deviation.
As defined in Marshall et al., 1991.